Vertex Pharmaceuticals' Revenue Forecast Tops Expectations
Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...
Top Vertex exec to retire after more than 12 years with company
Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue growth over the past decade.
StockStory.org on MSN6h
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top Estimates
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results , with sales up 15.7% year on year to $2.91 ...
Vertex's Revenue Surges but EPS Slips
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
KOIN Portland on MSN2h
Oregon sees uptick in flu cases
Oregon is one of 43 states showing a surge in flu activity. New data from the CDC shows doctor visits for the flu are at ...
Local businesses are feeling the effects of rising egg prices due to the Bird Flu
This norovirus case marks the seventh gastrointestinal illness outbreak on cruises this year that reached the CDC's threshold ...